Upload Button Icon Add office photos
filter salariesFilter salaries by

EMMES Corporation Clinical Research Associate 2 salaries in India (Updated 2025)

Annual salary range
Select experience
₹1.4 Crore - ₹1.5 Crore
Low Confidence
info icon
Low confidence means that this average salary is based on data that was reported by very few people.
Salary of majority employees
unlock blur
unlock blur

Interested in this particular role?

Last Updated: 24 Jan 2025

Companies similar to EMMES Corporation for Clinical Research Associate 2

Company name Avg Annual Salary Open Jobs
Logo
IQVIA Clinical Research Associate 2 Salary

2 - 9 years exp. (18 salaries)

unlock blur

₹6.2 L/yr - ₹12.7 L/yr

arrow icon 93% less
unlock blur

₹4.3 L/yr - ₹9.3 L/yr

arrow icon 95% less
Logo
unlock blur

₹10 L/yr - ₹12.5 L/yr

arrow icon 93% less
unlock blur

₹8 L/yr - ₹10 L/yr

arrow icon 94% less
unlock blur

₹11.3 L/yr - ₹14.6 L/yr

arrow icon 91% less

Mark your calendar for
Women @ Work from Mar 6-8

Grow your career with industry insights, exclusive jobs & exciting rewards

Clinical Research Associate 2 salary at EMMES Corporation ranges between ₹1.4 Crore to ₹1.5 Crore per year for employees with 8 years of experience. Salary estimates are based on 1 latest salaries received from various employees of EMMES Corporation.

Similar Designation salaries in EMMES Corporation

Clinical Data Analyst Salary
(AmbitionBox Estimate)
unlock blur
₹9.5 L/yr - ₹12.1 L/yr
unlock blur
₹6.5 L/yr - ₹7.5 L/yr

EMMES Corporation Clinical Research Associate 2 Salary FAQs

What is the notice period for Clinical Research Associate 2 at EMMES Corporation?
According to AmbitionBox, 100% of the EMMES Corporation Clinical Research Associate 2s reported a notice period of 2 Months.This is based on 1 response on AmbitionBox in last 2 years.

Tell us how to improve this page.

EMMES Corporation Clinical Research Associate 2 salary in India ranges between ₹1.4 Crore to ₹1.5 Crore. This is an estimate based on latest salaries received from employees of EMMES Corporation.